Interferon gamma producing blood lymphocytes are decreased by interferon beta therapy in patients with multiple sclerosis

Multiple Sclerosis

Volumn 3, Issue 3, 1997, Pages 180-183

  Petereit, H F ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Immunomodulatory therapy; Indicator of therapeutical effectiveness; Interferon beta therapy; Interferon gamma; Multiple sclerosis

Indexed keywords

BETA INTERFERON; GAMMA INTERFERON;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE; LYMPHOCYTE COUNT; MALE; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030817203     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/135245859700300302     Document Type: Article

References (3)

1. Huber M, Bamborschke S, Assheuer J, Heiß WD. (1988) Intravenous natural beta Interferon treatment of chronic exacerbating-remitting multiple sclerosis: clinical response and MRI/CSF findings. J Neurol 235: 171-173.
2. Arnason BG. (1993) Interferon beta in multiple sclerosis. Neurology 43: 641-643.
3. Jacobs L, Johnson KP. (1994) A brief history of the use of interferons as treatment of multiple sclerosis. Arch Neurol 51: 1245-1252.